Galectin‐3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients

BACKGROUND: Obesity is a precursor to heart failure with preserved ejection fraction. Biomarkers that identify preclinical metabolic heart disease (MHD) in young obese patients would help identify high‐risk individuals for heart failure prevention strategies. We assessed the predictive value of GAL3...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Gopal, Deepa M., Ayalon, Nir, Wang, Yi‐Chih, Siwik, Deborah, Sverdlov, Aaron, Donohue, Courtney, Perez, Alejandro, Downing, Jill, Apovian, Caroline, Silva, Vanessa, Panagia, Marcello, Kolachalama, Vijaya, Ho, Jennifer E., Liang, Chang‐seng, Gokce, Noyan, Colucci, Wilson S.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6509711/
https://ncbi.nlm.nih.gov/pubmed/30929550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.011100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados